ADGRG1 and acute myeloid leukemia: To validate the findings in AML patients, we sorted ADGRG1+/−CD8+ T cells from 4 AML with RUNX1::RUNX1T1 BM samples for bulk RNA-seq (Fig. 6C, Supplementary Figure S7B, Supplementary Table S8).